Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kemwell Biopharma is a leading biologics-focused CDMO based in Bangalore, India. It offers integrated development and manufacturing services for mammalian cell culture-based protein therapeutics—including monoclonal antibodies, bispecifics, fusion proteins—covering preclinical to commercial stages. The company has supported US IND trials up to Phase III batch production and has been licensed for commercial drug substance manufacture. Its facilities are cGMP-compliant with over 4000L bioreactor capacity. In recent years it expanded into cell therapy GMP manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kemwell Biopharma.